Pacira Biosciences, Stock Price Prediction
| PCRX Stock | USD 17.38 0.35 2.06% |
Oversold Vs Overbought
56
Oversold | Overbought |
Using Pacira BioSciences, hype-based prediction, you can estimate the value of Pacira BioSciences, from the perspective of Pacira BioSciences, response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Pacira BioSciences, to buy its stock at a price that has no basis in reality. In that case, they are not buying Pacira because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Pacira BioSciences, after-hype prediction price | USD 17.38 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Pacira |
Pacira BioSciences, After-Hype Price Prediction Density Analysis
As far as predicting the price of Pacira BioSciences, at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Pacira BioSciences, or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Pacira BioSciences,, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Pacira BioSciences, Estimiated After-Hype Price Volatility
In the context of predicting Pacira BioSciences,'s stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Pacira BioSciences,'s historical news coverage. Pacira BioSciences,'s after-hype downside and upside margins for the prediction period are 15.00 and 19.76, respectively. We have considered Pacira BioSciences,'s daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Pacira BioSciences, is not too volatile at this time. Analysis and calculation of next after-hype price of Pacira BioSciences, is based on 3 months time horizon.
Pacira BioSciences, Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Pacira BioSciences, is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Pacira BioSciences, backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Pacira BioSciences,, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.31 | 2.38 | 0.00 | 0.01 | 0 Events / Month | 1 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
17.38 | 17.38 | 0.00 |
|
Pacira BioSciences, Hype Timeline
Pacira BioSciences, is at this time traded for 17.38. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.01. Pacira is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is at this time at 0.31%. %. The volatility of related hype on Pacira BioSciences, is about 13600.0%, with the expected price after the next announcement by competition of 17.37. About 98.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.03. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Pacira BioSciences, recorded a loss per share of 1.98. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next projected press release will be within a week. Check out Pacira BioSciences, Basic Forecasting Models to cross-verify your projections.Pacira BioSciences, Related Hype Analysis
Having access to credible news sources related to Pacira BioSciences,'s direct competition is more important than ever and may enhance your ability to predict Pacira BioSciences,'s future price movements. Getting to know how Pacira BioSciences,'s peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Pacira BioSciences, may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| PAHC | Phibro Animal Health | 0.00 | 0 per month | 1.72 | 0.05 | 3.86 | (2.45) | 9.05 | |
| RDY | Dr Reddys Laboratories | 0.00 | 0 per month | 0.00 | (0.27) | 1.46 | (2.20) | 6.89 | |
| COLL | Collegium Pharmaceutical | 0.00 | 0 per month | 0.00 | (0.17) | 3.23 | (4.47) | 12.29 | |
| SSIC | Silver Spike Investment | 0.00 | 0 per month | 0.88 | 0.14 | 3.36 | (1.54) | 8.15 | |
| PBH | Prestige Brand Holdings | 0.00 | 0 per month | 0.97 | 0.11 | 1.90 | (1.76) | 4.90 | |
| HCM | HUTCHMED DRC | (0.21) | 11 per month | 2.67 | (0.03) | 5.32 | (5.01) | 12.71 | |
| IXHL | Incannex Healthcare Ltd | 0.00 | 0 per month | 5.40 | 0.02 | 10.05 | (10.66) | 28.99 | |
| EGRX | Eagle Pharmaceuticals | 0.00 | 0 per month | 0.00 | (0.30) | 9.24 | (9.34) | 52.42 | |
| ANIP | ANI Pharmaceuticals | 0.00 | 0 per month | 0.00 | (0.12) | 3.70 | (3.75) | 10.82 | |
| DCPH | Deciphera Pharmaceuticals LLC | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ITCI | Intracellular Th | 0.00 | 0 per month | 1.33 | 0.06 | 3.04 | (2.53) | 16.17 | |
| ALKS | Alkermes Plc | 0.00 | 0 per month | 0.00 | (0.06) | 4.14 | (3.59) | 9.74 |
Pacira BioSciences, Additional Predictive Modules
Most predictive techniques to examine Pacira price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Pacira using various technical indicators. When you analyze Pacira charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Pacira BioSciences, Predictive Indicators
The successful prediction of Pacira BioSciences, stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Pacira BioSciences,, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Pacira BioSciences, based on analysis of Pacira BioSciences, hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Pacira BioSciences,'s market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Pacira BioSciences,'s related companies.
Story Coverage note for Pacira BioSciences,
The number of cover stories for Pacira BioSciences, depends on current market conditions and Pacira BioSciences,'s risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Pacira BioSciences, is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Pacira BioSciences,'s long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Pacira BioSciences, Short Properties
Pacira BioSciences,'s future price predictability will typically decrease when Pacira BioSciences,'s long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Pacira BioSciences, often depends not only on the future outlook of the potential Pacira BioSciences,'s investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Pacira BioSciences,'s indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 52 M | |
| Cash And Short Term Investments | 278.6 M |
Additional Tools for Pacira Stock Analysis
When running Pacira BioSciences,'s price analysis, check to measure Pacira BioSciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacira BioSciences, is operating at the current time. Most of Pacira BioSciences,'s value examination focuses on studying past and present price action to predict the probability of Pacira BioSciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacira BioSciences,'s price. Additionally, you may evaluate how the addition of Pacira BioSciences, to your portfolios can decrease your overall portfolio volatility.